# Ranolazine

NDC: 60687-549
Generic name: Ranolazine
Labeler / Manufacturer: American Health Packaging
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20200819

FDA application: ANDA210054

## Active ingredients

- RANOLAZINE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60687-549"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60687-549
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90c5a0c2-542c-467e-9c0c-ef320534c560